| Literature DB >> 29482908 |
Sofie Louise Rygård1, Lars Broksø Holst1, Anders Perner2.
Abstract
The critical care and perioperative settings are high consumers of blood products, with multiple units and different products often given to an individual patient. The recommendation of this review is always to consider the risks and benefits for a specific blood product for a specific patient in a specific clinical setting. Optimize patient status by treating anemia and preventing the need for red blood cell transfusion. Consider other options for correction of anemia and coagulation disorders and use an imperative non-overtransfusion policy for all blood products.Entities:
Keywords: Anemia; Critical care; ICU; Perioperative; Plasma; Platelets; Red blood cells; Thrombocytes
Mesh:
Year: 2018 PMID: 29482908 DOI: 10.1016/j.ccc.2017.12.005
Source DB: PubMed Journal: Crit Care Clin ISSN: 0749-0704 Impact factor: 3.598